EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Total 25-Hydroxyvitamin D, Fibroblast Growth Factor-23, and Biochemical and Hematological Markers in Patients with Diabetic Nephropathy

Anas Hameed Mezher, Şevki Adem, Zeyad Adil Hameed, Nadia Murshed Abed

Iraqi Journal of Medical and Health Sciences · 10.11.2026 · 3 (2) · 7-16

DOI: 10.51173/ijmhs.v3i2.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iraqi Journal of Medical and Health Sciences, online erschienen am 10.11.2026. Verfasst von Anas Hameed Mezher und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Damage to the kidneys' tiny blood capillaries from chronically high blood glucose levels reduces their efficacy in filtering the blood of waste products and excess fluids. Objective of study: The aim of the present study is to investigate the biochemical parameters, lipid profile, haematological indices, serum total 25-hydroxyvitamin D [25(OH)D], and fibroblast growth factor-23 (FGF-23) in the cross-sectional investigation of individuals with diabetic nephropathy. Materials and Methods: A total of 180 people are participated in this study. Of these, 60 are designated as healthy controls, 60 as patients with chronic kidney disease (CKD) who did not have diabetes, and 60 as patients with diabetic nephropathy and chronic kidney disease (DMCKD). The following parameters are measured in fasting blood samples: glucose, urea, creatinine, calcium, total cholesterol, triglycerides, HDL-C, LDL-C, VLDL-C, and complete blood count. Serum total 25(OH)D is measured by enzyme-linked fluorescent assay (ELFA), and FGF-23 by enzyme-linked immunosorbent assay (ELISA). Suitable parametric or non-parametric tests are also used to compare groups, with a specific correlation analysis.

Results

Fasting blood glucose, urea, creatinine, triglycerides, and VLDL-C are significantly altered in the patient groups. However, HDL-C, hemoglobin, erythrocyte count, hematocrit, and platelet count are reduced compared to controls (p < 0.001 for most comparisons). Total 25(OH)D levels are lower in CKD and DMCKD patients than in controls, whereas FGF-23 levels are highest in the DMCKD group. Most correlations between total 25(OH)D, FGF-23, and biochemical markers are weak or non-significant, although FGF-23 shows a significant positive correlation with cholesterol in CKD patients.

Conclusions

Low total 25(OH)D status and increased FGF-23 may accompany renal impairment and metabolic disturbances in diabetic nephropathy and may contribute to laboratory monitoring when interpreted together with conventional renal, lipid, and hematological markers.

Zitieren

APA

Mezher, A. H., Adem, Ş., Hameed, Z. A., & Abed, N. M. (2026). Serum Total 25-Hydroxyvitamin D, Fibroblast Growth Factor-23, and Biochemical and Hematological Markers in Patients with Diabetic Nephropathy. Iraqi Journal of Medical and Health Sciences, 3(2), 7-16. https://doi.org/10.51173/ijmhs.v3i2.112

Vancouver

Mezher AH, Adem Ş, Hameed ZA, Abed NM. Serum Total 25-Hydroxyvitamin D, Fibroblast Growth Factor-23, and Biochemical and Hematological Markers in Patients with Diabetic Nephropathy. Iraqi Journal of Medical and Health Sciences. 2026;3(2):7-16. doi:10.51173/ijmhs.v3i2.112

BibTeX
@article{Mezher2026,
  author = {Mezher, Anas Hameed and Adem, Şevki and Hameed, Zeyad Adil and Abed, Nadia Murshed},
  title = {Serum Total 25-Hydroxyvitamin D, Fibroblast Growth Factor-23, and Biochemical and Hematological Markers in Patients with Diabetic Nephropathy},
  journal = {Iraqi Journal of Medical and Health Sciences},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {7--16},
  doi = {10.51173/ijmhs.v3i2.112}
}
Kostenlos starten →